Evolving strategies for the outpatient management of advanced heart failure

Om, 1992, Inotropic therapy of the failing myocardium, Clin Cardiol, 16, 5, 10.1002/clc.4960160103 Weintraub, 1993, New concepts in congestive heart failure, Clin Cardiol, 16, 380, 10.1002/clc.4960160504 Gheorghiade, 1991, Digoxin — a neurohormonal modulator in heart failure?, Circulation, 84, 2181, 10.1161/01.CIR.84.5.2181 Gheorghiade, 1992, Review of randomized trials of digoxin therapy in patients with chronic heart failure, Am J Cardiol, 69, 48G, 10.1016/0002-9149(92)91254-2 Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-convertingenzymes inhibitors, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101 DiBianco, 1989, A comparison of oral milrinone digoxin and their combination in the treatment of patients with chronic heart failure, N Engl J Med, 320, 677, 10.1056/NEJM198903163201101 Rajfer, 1984, Beneficial effects of oral levodopa in heart failure. Relation to the generation of dopamine, N Engl J Med, 310, 1357, 10.1056/NEJM198405243102105 Leier, 1982, Drug-induced conditioning in congestive heart failure, Circulation, 65, 1382, 10.1161/01.CIR.65.7.1382 Liang, 1979, Conditioning effects of chronic infusions of dobutamine, J Clin Invest, 64, 613, 10.1172/JCI109501 Miller, 1991, Outpatient dobutamine for refractory congestive heart failure: advantages techniques and results, J Heart Lung Transplant, 10, 482 Packer, 1991, Effect of oral milrinone on mortality in severe heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 Feldman, 1993, Effects of vesnarinone on morbidity and mortality in patients with heart failure, N Engl J Med, 329, 149, 10.1056/NEJM199307153290301 Kubo, 1992, Beneficial effects of pimobendan on exercise tolerance quality of life in patients with heart failure. Results of a multicenter trial, Circulation, 85, 942, 10.1161/01.CIR.85.3.942